Trial · NCT00470366
Adverse events73
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 73
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Paclitaxel, Ifosfamide, and Cisplatin | 19 | 60 | |
| other | Fatigue | General disorders | Paclitaxel, Ifosfamide, and Cisplatin | 17 | 60 | |
| other | Hemoglobin | Blood and lymphatic system disorders | Paclitaxel, Ifosfamide, and Cisplatin | 15 | 60 | |
| other | Leukocytes | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 13 | 60 | |
| other | Neutrophils/granulocytes | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 13 | 60 | |
| other | Platelets | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 13 | 60 | |
| other | ALT | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 11 | 60 | |
| other | Neuropathy: sensory | Nervous system disorders | Paclitaxel, Ifosfamide, and Cisplatin | 11 | 60 | |
| other | Hyponatremia | Metabolism and nutrition disorders | Paclitaxel, Ifosfamide, and Cisplatin | 11 | 60 | |
| other | Hyperglycemia | Metabolism and nutrition disorders | Paclitaxel, Ifosfamide, and Cisplatin | 10 | 60 | |
| other | AST | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 9 | 60 | |
| other | Hypoalbuminemia | Metabolism and nutrition disorders | Paclitaxel, Ifosfamide, and Cisplatin | 9 | 60 | |
| other | Alkaline phosphatase | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 9 | 60 | |
| other | Vomiting | Gastrointestinal disorders | Paclitaxel, Ifosfamide, and Cisplatin | 9 | 60 | |
| other | Hypomagnesemia | Metabolism and nutrition disorders | Paclitaxel, Ifosfamide, and Cisplatin | 8 | 60 | |
| other | Rash: acne/acneiform | Skin and subcutaneous tissue disorders | Paclitaxel, Ifosfamide, and Cisplatin | 8 | 60 | |
| other | Lymphopenia | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 7 | 60 | |
| other | Tinnitus | Ear and labyrinth disorders | Paclitaxel, Ifosfamide, and Cisplatin | 7 | 60 | |
| other | Hyperbilirubinemia | Investigations | Paclitaxel, Ifosfamide, and Cisplatin | 6 | 60 | |
| other | Diarrhea | Gastrointestinal disorders | Paclitaxel, Ifosfamide, and Cisplatin | 6 | 60 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00470366/events